{"raw_mentions": "Since there are no sentences that contain all four required components (molecule name, bioactivity metric, numeric value, and unit), the output is empty."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The half maximal binding concentrations (EC50) of inhibitors to indicated vDUBs were determined by established methods [2] and are listed in Table 2.\n* The IC50 values were determined as the concentrations of inhibitors that reduced deubiquitination or delSGylation activity by 50% (Table 2).\n* Viral proteases (1 \u03bc\u039c) were immobilized in microtiter plates.\n* Serial dilutions of FLAG-tagged inhibitor or Ub (up to 4 \u03bc\u039c, 24 points) were added and incubated for 20 min at room temperature.\n* Experiments were performed as described in (A) except the concentration of Ub was increased (up to 10 mM, 24 serial dilutions).\n\nNote that there are limited sentences that meet the criteria, and most of the text is descriptive of methods and experiments. The sentences extracted provide some context for the molecules and metrics mentioned, but the actual values and units are mostly referenced in tables that are not provided in the text snippet."}
{"final_json": [{"molecule_name": null, "protein_target_name": "vDUBs", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "viral proteases", "protein_target_name": "viral proteases", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "1", "unit": "\u03bc\u039c"}, {"molecule_name": "FLAG-tagged inhibitor or Ub", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "4", "unit": "\u03bc\u039c"}, {"molecule_name": "Ub", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "mM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe half maximal binding concentrations (EC50) of inhibitors were determined as described in Figure 5A and are listed in Table 3.\nThe IC50 values were determined as the concentrations of inhibitors that reduced deubiquitination or delSGylation activity by 50% (Table 3)."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nME.4 (deubiquitination IC50 = 0.8 nM and delSGlyation IC50 = 1.2 nM) and CC.4 (deubiquitination IC50 = 3.3 nM and delSGlyation IC50 = 11 nM), respectively (Table 2)."}
{"final_json": [{"molecule_name": "ME.4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.8", "unit": "nM"}, {"molecule_name": "ME.4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "1.2", "unit": "nM"}, {"molecule_name": "CC.4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "3.3", "unit": "nM"}, {"molecule_name": "CC.4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "11", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nME.4 was mutated at position 46 from F to A, at position 64 from Y to E, and at position 70 from I to V to generate ME.4.1 (SEQ ID NO: 11). \nIC50 and EC50 values (Table 3) were also determined as described herein (see Figure 18). \nBinding curves of these inhibitors to CCHFV OTU are shown in Figure 26 and EC50 values were determined and are listed in Table 5. \nFurther preliminary experiments using differential scanning calorimetry (DSC) determined that ME. l and ME.3 exhibited higher Tm values (83.7\u00b0C and 83.9\u00b0C respectively) than ME.2 and ME.4 (47.5\u00b0C and 46.6\u00b0C respectively) (Fig. 20)."}
{"final_json": [{"molecule_name": "ME.4.1", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": "11", "binding_metric": null, "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": "CCHFV OTU", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": null, "unit": null}, {"molecule_name": "ME.1", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Tm", "value": "83.7", "unit": "\u00b0C"}, {"molecule_name": "ME.3", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Tm", "value": "83.9", "unit": "\u00b0C"}, {"molecule_name": "ME.2", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Tm", "value": "47.5", "unit": "\u00b0C"}, {"molecule_name": "ME.4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Tm", "value": "46.6", "unit": "\u00b0C"}]}
{"raw_mentions": "There are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text appears to be a list of references with brief descriptions of research studies, but it does not include specific data on bioactivity metrics. \n\nTherefore, there are no sentences to return."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* To measure the half maximal binding concentration (EC50) of inhibitors binding to viral proteases, the concentration of inhibitors or wild type Ub was varied from 0 to 4 \u03bc\u039c (24 points, 1:2 dilution), while the concentration of target proteins immobilized on the plate remained at 1 \u03bc\u039c.\n* IC50 values were calculated using the GraphPad Prism software with the built-in equation formula (non-linear regression curve).\n* Binding- constants KD were obtained by fitting the response wavelength shifts in the steady- state regions using single -site binding system (Eq. 1) shown below.\n* IC50 values were calculated using the GraphPad Prism software with the built-in equation formula (non-linear regression curve).\n* Inhibition assays using Ub-AMC or ISG15-AMC (both Boston Biochem) as deconjugation substrates were performed as described before [1, 3] . Experiments were performed in assay buffer (50 niM HE PES, pH 7.5, 0.01% Tween 20, 1 mM dithiothreitol (DTT)) containing 1 \u03bc\u039c Ub-AMC substrate, 10 nM viral DUBs (vDUBs) and 12 serial dilutions of inhibitor.\n* Inhibition assays using Biotin Tetra-Ub/Ub4 WT Chains (K48- or K63-linked, Boston Biochem) as deubiquitination substrates were performed in assay buffer (50 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM DTT) containing 1 \u03bc\u039c substrate, 1 \u03bc\u039c vDUB and 10 \u03bc\u039c inhibitor as indicated."}
{"final_json": [{"molecule_name": null, "protein_target_name": "viral proteases", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "4", "unit": "\u03bc\u039c"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": "Ub-AMC", "protein_target_name": "viral DUBs (vDUBs)", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "Biotin Tetra-Ub/Ub4 WT Chains", "protein_target_name": "vDUB", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "\u03bc\u039c"}]}
